Paid
FEATURED
Pharma.AI (Insilico Medicine)
Generative AI platform for drug discovery and aging research.
Auto-generated snapshot
An end-to-end AI suite including tools for target discovery (PandaOmics), de novo molecule generation (Chemistry42), and clinical trial outcome prediction (InClinico). It designed the first AI-discovered drug for idiopathic pulmonary fibrosis currently in Phase II trials.
PROS
- + Validated end-to-end platform with an AI-discovered drug in Phase II clinical trials
- + Significantly reduces drug discovery and development timelines (e.g.
- + target to PCC in under 18 months)
- + Uses generative AI to design completely novel molecules from scratch (de novo generation)
- + Integrates target discovery (PandaOmics)
- + chemistry (Chemistry42)
- + and clinical prediction (InClinico) in one suite
- + Scalable
- + enterprise-grade solution used in multi-billion dollar pharmaceutical partnerships
CONS
- - Requires custom enterprise or licensing agreements
- - making it inaccessible for individual users
- - Complexity requires specialized expertise in drug discovery
- - chemistry
- - and AI/ML
- - Platform focus is on discovery and prediction
- - not late-stage clinical operations or manufacturing
-
Identifying novel and high-potential drug targets for complex diseases using PandaOmics
-
Generating de novo molecular structures with desired physicochemical properties using Chemistry42
-
Predicting clinical trial success probabilities and optimizing design parameters with InClinico
-
Accelerating the timeline from target identification to preclinical candidate nomination
-
Analyzing multi-omics and clinical data to discover disease signatures
SIMILAR TOOLS
CL
Claude Healthcare
Claude helps healthcare organizations move faster without sacrificing accuracy, safety, or compliance. Less administrative work, more time with the people you serve.
CH
ChatGPT Health
A dedicated experience in ChatGPT designed for health and wellness.
Verily
Precision health platform for research and patient care.
Medtronic (AI Surgery & Diabetes)
AI integrated into surgical robotics and chronic disease.